Navigating the Cellular Maze: Innovative Strategies for Targeted Drug Delivery in Cervical Cancer

Abstract

Cervical Cancer is a major health concern around the world including those regions which are limited in healthcare resources. The intricacies of this illness necessitates new and alternate methods to help treat its complexities. Researchers are therefore exploring means of targeted drug delivery that would deliver medications right to the cancer cells, minimizing side effects elsewhere in the human body. That targeted approach can increase treatment effectiveness. There are a lot of delivery systems available such as nanoparticles, liposomes, polymeric micelles and micellar systems, hydrogels or local drug delivery devices. They address matters, such as drug resistance and ensuring the targeted site of the body receives the dose. On top of that, emerging targeting strategies involving tumor -specific ligands, immunotherapy, virotherapy, and gene therapy look promising to develop more selective and efficacious treatments at a preclinical stage. Through the heavy focus on the complicated cellular pathways implicated in cervical cancer, these new approaches will make way for increased individualized and efficacious treatments. There is a need for further research to be carried out in the area of targeted drug delivery and the evolving targeting strategy, which is apparent through the literature. It remains a central goal with continued development of these strategies, we already know that this heralds increased clinical benefit and quality of life for cervical cancer patients worldwide. The synergy of novel drug delivery techniques combined with targeted approaches hold promise in modifications towards an era when cervical cancer can be better managed or even eradicetd.